DEVELOPMENT OF PERSONALIZED CANCER VACCINES TARGETING TUMOR HETEROGENEITY AND REPROGRAMMING THE COLD TUMOR MICRO-ENVIRONMENT IN KIDNEY CANCER
$1,270,020FY2025Defense Health AgencyDOD
The General Hospital Corporation
Investigators
View source on USAspending →DEVELOPMENT OF PERSONALIZED CANCER VACCINES TARGETING TUMOR HETEROGENEITY AND REPROGRAMMING THE COLD TUMOR MICRO-ENVIRONMENT IN KIDNEY CANCER · GrantIndex